Lundbeck Foundation
- Paul Little
Paul Little joined the early-stage biotech investment unit Lundbeckfonden Emerge in 2016 as an associate.
Paul’s focus is on scientific evaluation and commercial assessment of early investment opportunities. He is CEO of Vesper Biotechnology and Board representative in Folium.
Org chart
Sign up to view 0 direct reports
Get started
Offices
This person is not in any offices